CIK 0000313143
- Large accelerated filer
HAEMONETICS CORP
Sign in to watch- Ticker
- HAE
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Apr 3
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 042882273
- Phone
- +1 781-848-7100
- Business address
- 125 SUMMER STREET, BOSTON, MA, 02110
- 4 Open-market sale Director sold 4,337 shares at an average $35.14 ($152,398)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 14,685 shares at an average $35.35 ($519,105)
- 4 Open-market buy President & CEO bought 60,000 shares at $35.00 ($2,099,754)
- 4 Grant or award Director acquired 5,746 shares (grant or award)
- 4 Grant or award Director acquired 5,746 shares (grant or award)
- 4 Grant or award Director acquired 5,746 shares (grant or award)
- 4 Grant or award Director acquired 5,746 shares (grant or award)
- 4 Grant or award Director acquired 5,746 shares (grant or award)
- 4 Grant or award President & CEO acquired 45,867 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP, Global Manufacturing acquired 9,765 shares (grant or award)
- 4 Grant or award EVP, Global Human Resources acquired 8,138 shares (grant or award)
- 4 Grant or award EVP and Chief Legal Officer acquired 9,765 shares (grant or award)
- 4 Grant or award CFO & EVP Business Development acquired 11,393 shares (grant or award)
- 4 Grant or award President, Global Markets acquired 8,138 shares (grant or award)
- 4 Open-market sale President, Global Markets sold 344 shares at $32.13 ($11,052)
- 4 Open-market sale Chief Science and Technology sold 319 shares at $32.13 ($10,249)
- 4 Open-market sale EVP and Chief Legal Officer sold 778 shares at $32.13 ($24,996)
- 4 Open-market sale VP Finance sold 497 shares at $32.13 ($15,968)
Page 22 of 60 · 1,191 filings